BCAM-AKT2 fusion protein promotes unfolded protein response driven oncogenic signaling in SKOV3 epithelial ovarian cancer cell line
PLOS One · 2026
DOI: 10.1371/journal.pone.0357882 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Hala Khazem und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gynecologic Oncology Laboratory, Division of Obstetrics and Gynecology, Hillel Yaffe Medical Center, Hadera, Israel. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Unfolded Protein Response, Signal Transduction, Ovarian Neoplasms. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In view of the rapidly increasing evidence that gene fusion mutations are frequent drivers of cancer, a deeper understanding of the molecular and functional hallmarks of specific gene fusions in epithelial ovarian cancer (EOC) is essential. In this work we sought to identify the molecular signature of the BCAM-AKT2 fusion protein in ovarian cancer cell lines and to assess the biological impact of the novel fusion in these cells. Our in-vitro results show that the BCAM-AKT2 fusion protein is engaged in proliferative action within EOC cell lines. Furthermore, RNA-seq analysis shows that the effect of BCAM-AKT2 in SKOV3 cells is associated with activated unfolded protein response (UPR) and with the inhibition of interferon alpha and beta signaling pathways, pyropstosis and viral response in EOC cell lines. Overall, our results indicate that in SKOV3 cells, BCAM-AKT2 modulates the UPR signaling pathway, which is known to interact with oncogene and tumor suppressor networks during cancer development. These findings offer fresh insights suggesting that BCAM-AKT2 could serve as a promising target for therapeutic interventions in ovarian cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Gynecologic Oncology Laboratory, Division of Obstetrics and Gynecology, Hillel Yaffe Medical Center, Hadera, Israel.
- The Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
- Division of Obstetrics and Gynecology, Hillel Yaffe Medical Center, Hadera, Israel.
- Department of Human Molecular Genetics and Biochemistry, Gray Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel.
ORCID-Profile: Ravid Solomon Zemler, Liron Vardi David, Ilan Bruchim
Zitieren
APA
Khazem, H., Zemler, R. S., David, L. V., Reder, D., Sharon, S. M., Hantisteanu, S., Werner, H., & Bruchim, I. (2026). BCAM-AKT2 fusion protein promotes unfolded protein response driven oncogenic signaling in SKOV3 epithelial ovarian cancer cell line. PLOS One. https://doi.org/10.1371/journal.pone.0357882
Vancouver
Khazem H, Zemler RS, David LV, Reder D, Sharon SM, Hantisteanu S, et al. BCAM-AKT2 fusion protein promotes unfolded protein response driven oncogenic signaling in SKOV3 epithelial ovarian cancer cell line. PLOS One. 2026. doi:10.1371/journal.pone.0357882
BibTeX
@article{Khazem2026,
author = {Khazem, Hala and Zemler, Ravid Solomon and David, Liron Vardi and Reder, Dvir and Sharon, Shilhav Meisel and Hantisteanu, Shay and Werner, Haim and Bruchim, Ilan},
title = {BCAM-AKT2 fusion protein promotes unfolded protein response driven oncogenic signaling in SKOV3 epithelial ovarian cancer cell line},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0357882}
}
EUVIMED